Gastric Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Nov 15, 2004; 10(22): 3245-3250
Published online Nov 15, 2004. doi: 10.3748/wjg.v10.i22.3245
Figure 5
Figure 5 postoperative survivals of 79 gastric carcinoma patients. A: Shorter survival time of patients with high expression of wild-type survivin mRNA compared to patients with low expression of wild-type survivin expression (P = 0.003, log-rank test).B: No significance in expression of survivin-2B mRNA (P = 0.166, log-rank test). C: No significance in expression of survivin-△Ex3 mRNA (P = 0.441, log-rank test).